IP Library Assignment 037359/0831
Patent Assignment
Reel/Frame 037359/0831

Release of Security Interest

Recorded: 2015-12-24 Pages: 19
Assignor
BRIGHTSTAR ASSOCIATES, LLC
Executed: 2015-12-22
Assignee
DECIPHERA PHARMACEUTICALS, LLC
1601 TRAPELO ROAD, SUITE 152, WALTHAM, MASSACHUSETTS, 02451
Covered Properties (30)
Anti-Cancer Medicaments
Patent: 7,279,576 →
Application: 10/746,607 →
Publication: US 2004/0176395
Anti-Inflammatory Medicaments
Patent: 7,531,566 →
Application: 11/336,708 →
Publication: US 2008/0064688
Anti-Inflammatory Medicaments
Patent: 7,342,037 →
Application: 11/450,840 →
Publication: US 2007/0037808
Dihydropyridopyrimidinyl, Dihydronaphthyridinyl, and Related Compounds Useful as Kinase Inhibitors for the Treatment of Proliferative Diseases
Patent: 8,188,113 →
Application: 11/854,354 →
Publication: US 2008/0114006
Kinase Inhibitors Useful for the Treatment of Myleoproliferative Diseases and Other Proliferative Diseases
Patent: 7,790,756 →
Application: 11/870,388 →
Publication: US 2008/0090856
Enzyme Modulators and Treatments
Patent: 8,163,756 →
Application: 11/963,740 →
Publication: US 2008/0113967
Kinase Inhibitors Useful for the Treatment of Myleoprolific Diseases and Other Proliferative Diseases
Patent: 8,143,293 →
Application: 12/105,408 →
Publication: US 2008/0261965
N-Acyl Ureas Exhibiting Anti-Cancer and Anti-Proliferative Activities
Patent: 8,278,331 →
Application: 12/608,578 →
Publication: US 2010/0120806
Kinase Inhibitors Useful for the Treatment of Myleoproliferative Diseases and Other Proliferative Diseases
Patent: 8,586,565 →
Application: 12/829,561 →
Publication: US 2011/0136760
Pyridone Amides and Analogs Exhibiting Anti-Cancer and Anti-Proliferative Activities
Patent: 8,569,319 →
Application: 13/098,247 →
Publication: US 2012/0172382
Dihydronaphthyridines and Related Compounds Useful as Kinase Inhibitors for the Treatment of Proliferative Diseases
Patent: 8,461,179 →
Application: 13/491,394 →
Cyclopropyl Dicarboxamides and Analogs Exhibiting Anti-Cancer and Anti-Proliferative Activities
Patent: 8,637,672 →
Application: 13/559,170 →
Publication: US 2012/0322834
Cyclopropane Amides and Analogs Exhibiting Anti-Cancer and Anti-Proliferative Activities
Patent: 8,486,951 →
Application: 13/590,955 →
Publication: US 2013/0079362
Pyridone Amides and Analogs Exhibiting Anti-Cancer and Anti-Proliferative Activities
Patent: 8,921,565 →
Application: 13/683,277 →
Publication: US 2013/0317066
Raf Inhibitor Compounds
Patent: 8,741,911 →
Application: 13/785,575 →
Publication: US 2013/0252977
Dihydronaphthyridines and Related Compounds Useful as Kinase Inhibitors for the Treatment of Proliferative Diseases
Patent: 8,940,756 →
Application: 13/801,753 →
Publication: US 2014/0088075
Pyridone Amides and Analogs Exhibiting Anti-Cancer and Anti-Proliferative Activities
Patent: 9,012,635 →
Application: 14/214,127 →
Publication: US 2014/0343103
Imidazolidinones and Analogs Exhibiting Anti-Cancer and Anti-Proliferative Activities
Patent: 9,133,183 →
Application: 14/214,134 →
Publication: US 2014/0315917
1,2,4-Triazol-5-Ones and Analogs Exhibiting Anti-Cancer and Anti-Proliferative Activities
Patent: 9,193,719 →
Application: 14/214,160 →
Publication: US 2014/0296252
2-Aminopyrimidin-6-Ones and Analogs Exhibiting Anti-Cancer and Anti-Proliferative Activities
Patent: 9,181,223 →
Application: 14/214,171 →
Publication: US 2014/0275085
N-Acyl-N'-(pyridin-2-yl) Ureas and Analogs Exhibiting Anti-Cancer and Anti-Proliferative Activities
Patent: 9,309,224 →
Application: 14/214,179 →
Publication: US 2014/0275016
N-Acyl-N'-(Pyridin-2-Yl) Ureas and Analogs Exhibiting Anti-Cancer and Anti-Proliferative Activities
Patent: 9,382,228 →
Application: 14/214,185 →
Publication: US 2014/0275080
Raf Inhibitor Compounds
Patent: 9,334,267 →
Application: 14/383,799 →
Publication: US 2015/0119392
Raf Inhibitor Compounds
Patent: 9,187,474 →
Application: 14/383,803 →
Publication: US 2015/0105367
Methods for Inhibiting Tie-2 Kinase Useful in the Treatment of Cancer
Patent: 9,457,019 →
Application: 14/535,900 →
Publication: US 2015/0246033
Pyridone Amides and Analogs Exhibiting Anti-Cancer and Anti-Proliferative Activities
Patent: 9,387,202 →
Application: 14/549,125 →
Publication: US 2015/0148380
Dihydronaphthyridines and Related Compounds Useful as Kinase Inhibitors for the Treatment of Proliferative Diseases
Application: 14/560,809 →
Publication: US 2015/0320759
Cyclopropyl Dicarboxamides and Analogs Exhibiting Anti-Cancer and Anti-Proliferative Activities
Application: 14/602,781 →
Publication: US 2015/0218130
Iinhibition of Tumor Cell Interactions with the Microenvironment Resulting in a Reduction in Tumor Growth and Disease Progression
Application: 62/063,656 →
Inhibition of Trk Kinase Mediated Tumor Growth and Disease Progression
Application: 62/063,660 →
Related Assignments (8)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jul 9, 2013
From: FLYNN, DANIEL L.; KAUFMAN, MICHAEL D.; PETILLO, PETER A.
To: DECIPHERA PHARMACEUTICALS, LLC
Reel/Frame 030760/0705 →
Assignment of Assignor's Interest Oct 6, 2014
From: FLYNN, DANIEL L.; KAUFMAN, MICHAEL D.
To: DECIPHERA PHARMACEUTICALS, LLC
Reel/Frame 033895/0551 →
Assignment of Assignor's Interest Jan 29, 2015
From: FLYNN, DANIEL L.; KAUFMAN, MICHAEL D.; SMITH, BRYAN D.; RUDOLTZ, MARC
To: DECIPHERA PHARMACEUTICALS, LLC
Reel/Frame 034842/0186 →
Assignment of Assignor's Interest Feb 5, 2015
From: FLYNN, DANIEL L.; KAUFMAN, MICHAEL D.
To: DECIPHERA PHARMACEUTICALS, LLC
Reel/Frame 034894/0499 →
Security Interest Aug 10, 2015
From: DECIPHERA PHARMACEUTICALS, LLC
To: BRIGHTSTAR ASSOCIATES LLC
Reel/Frame 036288/0037 →
Security Interest Aug 10, 2015
From: DECIPHERA PHARMACEUTICALS, LLC
To: BRIGHTSTAR ASSOCIATES LLC
Reel/Frame 036315/0091 →
Security Interest Aug 10, 2015
From: DECIPHERA PHARMACEUTICALS, LLC
To: BRIGHTSTAR ASSOCIATES LLC
Reel/Frame 036315/0188 →
Release of Security Interest Dec 24, 2015
From: BRIGHTSTAR ASSOCIATES, LLC
To: DECIPHERA PHARMACEUTICALS, LLC
Reel/Frame 037359/0866 →